Open Insider Trading Activity for Alkermes Plc. EVP R&D, Chief Medical Officer Hopkinson Craig C.
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction ALKS | 2026-06-01 | 2026-06-01 | Alkermes Plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 1 | 9,000 | $41.67 | $375,030.00 | 10.42% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ALKS | 2026-05-01 | 2026-05-01 | Alkermes Plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 1 | 9,000 | $33.40 | $300,600.00 | 9.96% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ALKS | 2026-04-01 | 2026-04-01 | Alkermes Plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 1 | 9,000 | $35.51 | $319,590.00 | 9.54% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ALKS | 2025-12-05 | 2025-12-03 | Alkermes Plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 1 | 3,748 | $30.00 | $112,440.00 | 5.39% | View Filing |